Clinical Trials in Chicago

Showing 6681-6700 of 20,493 trials

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

NCT05600114

A phase 2, multicenter, double-blind, parallel group, placebo-controlled, randomized clinical study, designed to compare the efficacy, safety, and tolerability of 2 dose levels of CBD and a matching placebo for the treatment of subjects with Social Anxiety Disorder (SAD).

Social Anxiety Disorder

EmpowerPharm Inc.239 participantsStarted Oct 2022

Encino, California, United States • Lemon Grove, California, United States • Los Alamitos, California, United States +14 more locations

COMPLETEDNA2.2 miles

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

NCT03876457

SELECT 2 evaluates the efficacy and safety of endovascular thrombectomy compared to medical management alone in acute ischemic stroke patients due to a large vessel occlusion in the distal ICA and MCA M1 who have large core on either CT (ASPECTS: 3-5) or advanced perfusion imaging (\[rCBF\<30%\] on CTP or \[ADC\<620\] on MRI: ≥50cc) or both and are treated within 0-24 hours from last known well.

Acute Ischemic Stroke

University Hospitals Cleveland Medical Center352 participantsStarted Oct 2019

Los Angeles, California, United States • Jacksonville, Florida, United States • Chicago, Illinois, United States +28 more locations

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Find Trials by Condition in Chicago

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

TIPS Plus Transvenous Obliteration for Gastric Varices

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Age of Blood in Sickle Cell Transfusion

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial